404
C. Ramstadius et al. / Tetrahedron: Asymmetry 22 (2011) 399–405
H-2), 3.89–3.92 (2H, m, H-3, H-6), 4.07 (1H, d, J3,4 3.1 Hz, H-4), 4.17
J2,3 1.8 Hz, J3,4 3.5 Hz, H-3II), 4.03 (1H, d, J3,4 3.5 Hz, H-4II), 4.10
II
(1H, dat, Jat 1.4 Hz, J6,6 12.4 Hz, H-60), 4.38 (1H, d, J 11.8 Hz,
(1H, d, J6,6 12.1 Hz, H-60 ), 4.24 (1H, d, J 11.8 Hz, PhCHH0),
0
0
PhCHH0), 4.46 (2H, s, PhCH2), 4.51 (1H, d, J 11.8 Hz, PhCHH0),
4.58–4.60 (4H, m, H-1, PhCH2, PhCHH), 4.66 (1H, d, J 12.4 Hz,
PhCHH0), 5.87 (1H, m, H-5a), 7.21–7.23 (2H, m, Ar-H), 7.30–7.37
(18H, m, Ar-H); dC (125 MHz, CDCl3) 68.2 (d, C-1), 70.6 (t, C-6),
71.8, 72.1, 72.6, 73.6 (4 ꢂ t, 4 ꢂ PhCH2), 74.1 (d, C-3), 74.9 (d, C-
4), 80.5 (d, C-2), 127.9, 127.9, 127.9, 128.0, 128.0, 128.1, 128.4,
128.5, 128.5, 128.6 (10 ꢂ d, Ar-CH), 129.5 (d, C-5a), 134.3, 138.3,
138.4, 138.4, 138.5 (5 ꢂ s, C-5, 4 ꢂ Ar-C); m/z (ESI+) 559 (M+Na+,
100%); HRMS (ESI+) calcd for C35H36O5Na (M+Na+) 559.2455; found
559.2454.
4.38–4.58 (11H, m, H-1I, PhCHH0, PhCHH0, 4 ꢂ PhCH2), 4.62,
4.68 (2H, 2 ꢂ d, J 12.3 Hz, PhCH2), 4.80 (1H, d, J 11.8 Hz, PhCHH0),
5.73 (1H, s, H-5aII), 7.12–7.29 (35H, m, Ar-H); dC (125 MHz,
CDCl3) 47.2 (t, C-6I), 54.9 (q, OCH3), 54.9 (d, C-1II), 71.0 (t, C-
6II), 71.5, 71.8, 72.3, 73.0, 73.7, 75.1 (6 ꢂ t, PhCH2), 71.3, 74.9⁄,
75.0, 75.2, 76.8, 77.2 (6 ꢂ d, C-2I, C-4I, C-5I, C-2II, C-3II, C-4II),
80.4 (d, C-3I), 99.1 (d, C-1I), 127.6, 127.6, 127.7, 127.7, 127.7,
127.8, 127.8, 127.9, 128.0, 128.1, 128.4, 128.4, 128.5 (13 ꢂ d,
Ar-CH), 129.3⁄ (d, C-5aII), 134.2⁄ (s, C-5II), 138.5, 138.5, 138.6,
138.6, 138.7, 138.8 (6 ꢂ s, Ar-C); m/z (ESI+) 1004 (M+Na+, 27),
982 (M+H+, 100%); HRMS (ESI+) calcd for C63H68O9N 982.4889
(M+H+); found 982.4856; calcd for C63H67O9NNa 1004.4714
(M+Na+); found 1004.4639.
4.9. Methyl 6-N-[2,3,4,6-tetra-O-benzyl-5a-carba-
5(5a)-enopyranosyl]-6-amino-2,3,4-tri-O-benzyl-6-deoxy-6-N-
(2-nitrobenzenesulfonyl)- -mannopyranoside 15
a-D-lyxo-hex-
a
-D
⁄Low intensity signals.
Alcohol 9 (31 mg, 0.058 mmol) and sulfonamide 14 (46 mg,
0.071 mmol) were dissolved in toluene (2 mL) under Ar. Triphenyl-
phosphine (60 mg, 0.23 mmol) was added, and the resulting yel-
4.11. Methyl 6-N-[2,3,4,6-tetra-O-benzyl-5a-carba-b-
5(5a)-enopyranosyl]-6-amino-2,3,4-tri-O-benzyl-6-deoxy-6-N-
(2-nitrobenzenesulfonyl)- -mannopyranoside 17
D-lyxo-hex-
a-D
lowish solution was cooled to 0 °C. Next, DIAD (50 lL,
0.26 mmol) was added, and the reaction mixture was left to warm
slowly to rt. After 5.5 h, TLC (toluene–EtOAc, 4:1) indicated the for-
mation of a major product (Rf 0.6) and the presence of some
remaining alcohol (Rf 0.4) and sulfonamide (Rf 0.5) starting mate-
rials. The reaction mixture was concentrated in vacuo and the
crude residue was purified twice by flash column chromatography
(toluene?toluene–EtOAc, 30:1?15:1?10:1) to yield pseudodi-
saccharide 15 (41 mg, slightly contaminated by DIAD residue) as
a yellow oil; dH (500 MHz, CDCl3) 3.16 (3H, s, OCH3), 3.64–3.77
Alcohol 10 (30 mg, 0.056 mmol) and sulfonamide 14 (46 mg,
0.071 mmol) were dissolved in toluene (2 mL) under Ar. Triphenyl-
phosphine (60 mg, 0.23 mmol) was added, and the resulting yel-
lowish solution was cooled to 0 °C. Next, DIAD (48 lL,
0.25 mmol) was added, and the reaction mixture was left to warm
slowly to rt. After 5.5 h, TLC (toluene–EtOAc, 4:1) indicated the for-
mation of two products (Rf’s 0.7 and 0.6) and the presence of some
alcohol (Rf 0.2) and sulfonamide (Rf 0.5) starting materials. The
reaction mixture was concentrated in vacuo and the crude residue
purified twice by column chromatography (toluene?toluene–
EtOAc, 30:1?15:1 ?10:1), to yield an elimination product
(17 mg, 59%) as a colourless oil; data for the major component:
dH (400 MHz, CDCl3) 3.95–4.01 (2H, m, H-2, H-3), 4.39, 4.53 (2H,
2 ꢂ d, J 12.2 Hz, PhCH2), 4.44 (1H, m, H-4), 4.64–4.75 (4H, m,
2 ꢂ PhCH2), 4.89, 4.95 (2H, 2 ꢂ d, J 12.6 Hz, PhCH2), 5.72 (1H,
ddd, J 1.3 Hz, J 2.6 Hz, J1,5a 10.2 Hz, H-1), 6.09 (1H, s, H-6), 6.65
(1H, dat, Jat 1.0 Hz, J1,5a 10.2 Hz, H-5a), 7.15–7.17 (2H, m, Ar-H),
7.24–7.48 (18H, m, Ar-H).
I
(4H, m, H-2I, H-6I, H-60 ), 3.85–3.91 (3H, m), 4.00–4.03 (2H, m),
4.09–4.14 (2H, m, H-2II), 4.23 (2H, m, PhCH2), 4.33 (1H, d, J
11.8 Hz, PhCHH0), 4.44–4.71 (11H, m, H-1I, 4 ꢂ PhCH2, PhCHH0,
PhCHH0), 4.95–4.97 (2H, m, H-1II, PhCHH0), 5.80 (1H, s, H-5aII),
7.11–7.44 (38H, m, Ar-H), 7.90 (1H, d,
J 7.9 Hz, Ar-H); dC
(125 MHz, CDCl3) 47.7⁄ (t, C-6I), 55.4 (q, OCH3), 57.3⁄ (d, C-1II),
70.4, 70.7, 71.4, 72.1, 72.6, 72.8, 73.6, 74.5 (8 ꢂ t, C-6II, 7 ꢂ PhCH2),
74.4, 74.8, 77.0, 80.2 (4 ꢂ d), 99.0 (d, C-1I), 124.0, 127.4, 127.5,
127.6, 127.6, 127.7, 127.7, 127.8, 127.9, 128.1, 128.3, 128.3,
128.4, 128.4, 128.4, 128.5, 128.5 (17 ꢂ d, C-5aII, Ar-CH), 131.1,
131.2, 132.8 (3 ꢂ d, Ar-CH), 133.6 (s, C-5II), 138.2, 138.4, 138.4,
138.5, 138.5, 138.7, 138.8 (7 ꢂ s, Ar-C), 148.0, 150.2 (2 ꢂ s, Ar-C);
m/z (ESI+) 1189 (M+Na+, 100%); HRMS (ESI+) calcd for C69H70O13
N2SNa (M+Na+) 1189.4491; found 1189.4517.
And pseudodisaccharide 17 (13 mg, 20%) as a colourless oil;
dH (500 MHz, CDCl3) 2.97 (3H, s, OCH3), 3.24 (1H, at, J 9.0 Hz,
H-4I), 3.59–3.71 (4H, m, H-2I, H-3I, H-5I, H-6I), 3.90 (1H, d, J3,4
8.6 Hz, H-3II), 3.93 (1H, d, J6,6 12.6 Hz, H-6II), 4.09–4.12 (2H, m,
0
I
H-60 , PhCHH0), 4.28 (1H, d, J 10.7 Hz, PhCHH0), 4.33 (1H, d, J
⁄Signals nearly invisible, can be perceived as minor ‘bumps’
only. Many signals in the 1H NMR spectrum appear very broad. Sig-
nals are not observed for some carbons in the 13C NMR spectrum.
11.6 Hz, PhCHH0), 4.39 (1H, s, H-2II), 4.47–4.60 (8H, m, H-1I, H-
II
4II, H-60 , PhCHH0, 2 ꢂ PhCH2), 4.67 (1H, d, J 11.6 Hz, PhCHH0),
4.72–4.78 (3H, m, PhCHH0, 2 ꢂ PhCHH0), 4.83 (1H, s, H-1II), 4.86
(1H, d, J 10.8 Hz, PhCHH0), 4.97 (1H, d, J 10.8 Hz, PhCHH0), 6.15
(1H, s, H-5aII), 7.05–7.60 (36H, m, Ar-H), 7.61–7.66 (2H, m, Ar-
H), 7.98 (1H, d, J 8.0 Hz, Ar-H); dC (125 MHz, CDCl3) 49.8 (t, C-
6I), 54.7 (q, OCH3), 58.6 (d, C-1II), 70.1, 74.3, 80.1 (3 ꢂ d, C-2I,
C-3I, C-5I), 77.0⁄ (d, C-4II), 77.5⁄ (d, C-4I), 80.0 (d, C-2II), 83.9
(d, C-3II), 98.8 (d, C-1I), 123.9 (d, Ar-CH), 125.4 (d, C-5aII),
127.4, 127.5, 127.6, 127.7, 127.8, 127.8, 128.0, 128.2, 128.4,
128.4, 128.5, 128.5 (12 ꢂ d, Ar-CH), 131.8, 132.2, 133.6 (3 ꢂ d,
Ar-CH), 134.7 (s, C-5II), 138.0, 138.2, 138.4, 138.5, 138.7, 138.8,
138.9, 138.9, 148.1 (9 ꢂ s, 9 ꢂ Ar-C); m/z (ESI+) 1189 (M+Na+,
100%); HRMS (ESI+) calcd for C69H70O13N2SNa (M+Na+)
1189.4491; found 1189.4458.
4.10. Methyl 6-N-[2,3,4,6-tetra-O-benzyl-5a-carba-a-D-lyxo-hex-
5(5a)-enopyranosylamino]-2,3,4-tri-O-benzyl-6-deoxy-a-D-
mannopyranoside 16
Sulfonamide 15 (40 mg) was dissolved in DMF (1 mL), and
thiophenol (15 L, 0.15 mmol) was added. Potassium carbonate
l
(34 mg, 0.24 mmol) was added, and the resulting mixture was
heated to 50 °C. After 1 h 15 min, TLC (toluene–EtOAc, 4:1) indi-
cated the complete consumption of the starting material (Rf 0.7)
and the formation of a major product (Rf 0.1). The reaction mix-
ture was allowed to cool to rt and then concentrated in vacuo.
The crude product was purified by flash column chromatography
(toluene–EtOAc, 8:1?5:1?2:1, 1% NEt3) to yield the pseudodi-
saccharide amine 16 (29 mg, 51% over two steps) as a colourless
⁄Chemical shifts estimated from HSQC spectrum due to overlap
with CDCl3 peaks.
oil; ½a 2D2
ꢁ
þ 27:6 (c 1.0, CHCl3); dH (500 MHz, CDCl3) 2.69 (1H, dd,
Acknowledgement
J5,6 8.1 Hz, J6,6 12.0 Hz, H-6I), 2.86 (1H, dd, J5,6 2.1 Hz, J6,6
0
0
0
11.9 Hz, H-60 ), 3.17 (3H, s, OCH3), 3.58–3.71 (5H, m, H-2I, H-4I,
H-5I, H-1II, H-2II), 3.74–3.80 (2H, m, H-3I, H-6II), 3.84 (1H, dd,
We are grateful to Vetenskapsrådet (the Swedish research
council) for support.
I